Viatris Inc. (Nasdaq: VTRS) announced that the U.S. Food and Drug Administration has approved Ryzumvi (phentolamine ophthalmic solution 0.75%) for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA